Novavax COVID-19 Vaccine Adjuvanted from China
Novavax protein-based COVID-19 vaccine with Matrix-M adjuvant, in pre-filled syringes for measured retail doses. Classified as immunological product HTS 3002.15.00.
Duty Rate — China → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Saponin adjuvant certificates; hypersensitivity warnings
• 2-8°C storage; 30-day room temp stability post-thaw
• Bulk protein antigen as 3002.30 without adjuvant